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ABSTRACT
Effects of Lactobacillus rhamnosus Milk Isolate on the Production of Inflammatory
Cytokines in Enterocytes
by
Beverly C. Ngeny
In the gastrointestinal tract, probiotics have been shown to promote host immunity and
to regulate immune signaling pathways. This study used Caco-2 cell line to examine the
effects of a Lactobacillus rhamnosus isolate from “amabere amaruranu” a Kenyan
traditional cultured milk, on the production inflammatory cytokines in enterocytes. Live
Lactobacillus rhamnosus (MRS6AN), its cytoplasmic fraction (CF), filtered spent broth
(FSB) or heat inactivated FSB (HIB) were used as treatments on differentiated Caco-2
cell monolayer in transwells. Cytokine content in the cell lysates, apical and basolateral
supernatants were determined using ELISA. Caco-2 cell lysate treatments showed
significantly increased anti-inflammatory TGF-β (ng/ml) levels on average about 100x
more compared to the increase in pro-inflammatory IL-8 (pg/ml) levels. These levels
were significantly reduced after inhibition of NF-κB. In conclusion, live Lactobacillus
rhamnosus, its CF, FSB or HIB seemed to modulate the production of inflammatory
cytokines in enterocytes partly via the NF-κB signaling pathway.
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CHAPTER 1
INTRODUCTION

Probiotics
“Probiotics are live microorganisms that confer health beneﬁts to the host when
administered in adequate amounts” (FAO/WHO 2001). The term probiotic was derived
from the Greek word meaning “for life” (Reid et al. 2003). They are live commensal
microorganisms that majorly colonize the gastrointestinal tract where they regulate
intestinal epithelial development and function (Gaudana et al. 2010). Naidu et al. (1999),
described probiotics as dietary adjuncts that benefits the physiology of the host. They
modulate the immune system and improve the nutritional and microbial balance in the
gastrointestinal tract.
Predominant microbes in the human intestinal tract that have been identified are
lactic-acid producing gram positive Lactobacillus and Bifidobacterium genera (Gill and
Cross 2002). Probiotics are widespread in nature. Lactic acid bacteria naturally occur in
soil, water, sewage, silage and plants. They can be found in dietary supplements and
fermented products: beverages, bakery products, vegetables, meat, and milk. They can
also occur in mucous membranes of the human body such as the skin, mouth, urinary
and genital organs, (Harzallah and Belhadj 2013) and the intestine where they enhance
gastrointestinal system function (Schaafsma, 1996). They play an important role in the
fermentations of food and feeds which help to increase their shelf life (Bhutada and
Tambekar 2009).

12

For over a decade there has been an increase in the interest for use of probiotics
for prevention and treatment of various human diseases (Metchnikoff 1907). This is due
to the rise in number of pathogens that have multidrug resistance and the recognition of
the role in which commensal bacteria play in health and disease (Britton and Versalovic
2008). Currently, some probiotic compounds or metabolites are being used in the
management of gastrointestinal diseases such as in Inflammatory Bowel Disease (IBD)
therapy (Madsen et al. 1999; Shibolet et al. 2002). National Health Interview Survey
(NHIS) (2015), reported that 1.6% of US adults (3.9 million) and 0.5% of US children
(294,000) use probiotics (Clarke et al. 2012). Inasmuch as many milk products
containing probiotics are readily available in the market (Miyoshi, 2010), there is need
for more information on the mechanisms of these probiotics in order to consider them
for the treatment and prevention specific diseases (Ouwehand 2002).
The function of probiotics mainly occurs through their adaptation factors and
probiotic factors - health beneficial effects (Lebeer et al. 2008). Adaptation factors
include adherence to intestinal mucosa and mucus, stress tolerance and production of
antimicrobial products whereas probiotic factors mainly include maintenance of
microbial balance, epithelial protection and immune modulation (Medzhitov 2007).

Probiotic Potential in the Gastrointestinal Tract
Probiotic potential of microorganisms is dependent on their “viability, large scale
reproducibility, stability during use and storage and the ability to survive in the intestinal
ecosystem” (Boyiri and Onyango 2015). Probiotic adaptation factors include stress
13

tolerance, production of anti-microbial factors and impairment of pathogenic colonization
in the gastrointestinal tract (GIT). Studies by Guandalini (2002), showed that probiotics
produce adhesins which play a protective role by preventing the binding of pathogenic
bacteria to the intestinal epithelia. In vitro, studies have illustrated that probiotics have
lectin-like adhesive components that bind to carbohydrate form glyco-conjugate
receptors on intestinal epithelial cells (IEC) which prevent pathogens from binding
(Gourbeyre et al. 2010). Probiotics can also impair the growth and colonization of
pathogenic strains by producing antimicrobial products such as hydrogen peroxide,
bacteriocins (lantibiotics) and organic acids (lactic, acetic and propionic acids)
(Gourbeyre et al. 2010; Balamurugan et al. 2014).
Apart from producing antimicrobial compounds, probiotics exert intestinal
colonization by competing for receptors on the mucus layer or on intestinal epithelial
cells and via bacteria-bacteria communication in biofilms or microenvironment through
quorum sensing (Schiffrin and Blum 2002). Probiotics also stimulate enterocytes to
produce cyto-protective substances such as heat shock proteins (Tao et al. 2006) which
protect the intestinal epithelia from tissue damage. They also produce antimicrobial
peptides like defensins (Salzman et al. 2010) which “directly kill or inhibit the growth of
bacteria in the lumen” (Salim and Madsen 2014); and mucins (Mack et al. 1999) which
may directly limit intestinal infection by adhering to pathogens (Linden et al. 2008). They
also protect against secretion of gastric and duodenal acids (Purchiaroni et al. 2013).
In their ability to stimulate defensin production (Salim and Madsen 2014) and
activity (Britton and Versalovic 2008), probiotics can modify the ability of pathogens to
bind to or colonize colonic epithelial cells by seizing vital nutrients from pathogens or by
14

changing the pH making it unfavorable for pathogenic strains to survive (Schiffrin and
Blum 2002). Probiotics have also been shown to promote mucosal integrity and to “act
on tight junctions by increasing the expression of zonula occludens proteins and
occludins” (Shen et al. 2006; Gareau et al. 2010). Studies have pointed out that a good
number of probiotics are able to withstand the adverse environmental conditions of the
GIT including low pH or high acidity, high temperature, presence of bile salts, antibiotics
and they also play a major role in the promotion of the host immunity (Bhutada and
Tambekar, 2009; Leeber et al. 2012). Apart from their adaptation factors, probiotics also
confer health benefits to their hosts (Lebeer et al. 2008).

Health Effects of Probiotic Lactobacilli
Probiotics have beneficial effects in the intestinal tract in that they help to
stabilize the native microbial population, protect against intestinal infection, alleviate
lactose intolerance, reduce serum cholesterol levels and enhance non-specific immune
systems (Gaudana et al. 2010). Several studies have shown how Lactobacilli exert
health benefits to their hosts and how they have been used in the treatment and
prevention of enteric infections like acute infectious diarrhea, reduction of relapse of
Clostridium difficile associated diarrhea (Pillai et al. 2008) and prevention of antibioticassociated diarrhea (Sazawal et al. 2006). For example, Basu et al. (2009) in their study
reported that Lactobacillus rhamnosus doses (1010 and 1012 cfu) were both effective in
reducing the duration and frequency of acute watery diarrhea. In another study at a
daycare in Croatia by Hojsak et al. (2009), compared to the placebo group (n=142),
15

children who were given 100ml of fermented milk product with Lactobacillus rhamnosus
GG (109 cfu; n=139) had a significant reduction in respiratory tract infections. Clinical
studies have also reported the use of Lactobacilli in the treatment and prevention of
colorectal cancer (Rafter et al. 2007), inflammatory bowel disease - IBD (Hedin et al.
2007), bacterial vaginosis and urogenital diseases in women (Falagas 2007), prevention
of food hypersensitivity and atopic disease (Boyle et al. 2006), prevention of dental
caries (Meurman and Stamatova 2007) and treatment of irritable bowel syndrome
(Camilleri, 2006). However, it is important to consider the probiotic strain dosage and
the host’s health condition in determining the health benefits that probiotics may confer
to the host. The lowest daily dose of Lactobacillus rhamnosus reported to benefit the
host is 1 X 108 cfu/day (Kekkonen et al. 2009).

Immunological Importance of Probiotics in the GIT
Purchiaroni et al. (2013) stated that microbiota in the gut plays a crucial role in
the maintenance and disruption of gut immune latency by interacting with both innate
and adaptive immune system. Probiotics interact with a extensive variety of cells
including enterocytes, dendritic cells, T-helper 1, T-helper 2 and T-regulatory in the
gastrointestinal tract (GIT) and this enables them to either modulate or to promote proor anti-inflammatory immune responses (Gourbeyre et al. 2010). Intestinal Lactobacilli
and Bifidobacteria have specific components which have been linked with health effects
in the host such as the elevation of gut maturation and integrity, immune modulation
and antagonisms against pathogens (Schiffrin and Blum 2002). Probiotics that have an
16

anti-inflammatory potential, may reduce bacteria-induced production of proinflammatory cytokines or cause a decrease in serum C-reactive proteins (CRP) levels
(Galdeano et al. 2008; Mercola 2008). Gill and Cross (2002), in their research, found
that probiotics were able to modulate the immune system via both immune-stimulatory
and immune-regulatory mechanisms. However, selection of probiotic strain with
immunological properties: their ability to influence cytokine expression or to favor a
claimed immune response must be well defined (Perdigon et al. 2013). Immunological
effects of probiotics may also result from soluble factors that may alter epithelial
permeability, downregulates inflammatory cascade, or enhance activation, maturation,
or survival of dendritic cells (Corthesy et al. 2007).
Probiotics could also maintain intestinal immune homeostasis by reversing
immune dysbiosis and prevent inflammation (Schiffrin and Blum 2002). According to
Britton and Versalovic (2008), probiotics compete for an ecological niche and play a
vital role in the balance between homeostasis and dysbiosis. Consequently, deviations
from appropriate development and regulation of innate and adaptive immunity could
lead to dysbiosis, loss of metabolic and immune homeostasis. Probiotic bacteria have
the potential to reverse dysbiosis and restore tolerance towards the microbiota (Zeuthen
et al. 2008; Baarlen et al. 2013). Probiotics could therefore employ a twofold function;
stimulation of mucosal defense mechanism and maintenance of immune balance
(Schiffrin and Blum 2002). Delcenserie et al. (2008), in their studies, concluded that
probiotics can act on a variety of intestinal cells thereby modulating the immune system
towards a pro-inflammatory or anti-inflammatory responses depending on the strain
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used, the types of cells being treated, the setting and the immunological factors being
measured.
Enterocytes in Gastrointestinal Immunity
Enterocytes occur in a single monolayer forming a barrier that protects the
gastrointestinal tract from nearly 400 species: approximately 1014 bacteria (Pinto et al.
2009). Human colonial epithelial cells form the bowel mucosal barrier which play an
important role in the initiation and advancement of intestinal inflammation (Dimitrov and
Gotova 2014). Delcensenrie et al. (2008), examined how the interaction between
probiotics and enterocytes serve as an initiating event in immunomodulation and
suggested that the interaction between probiotics and the intestinal epithelial cells is a
central factor for production of cytokines by enterocytes before they interact with
immune system cells. Further, Perdigon et al. (2002) supported that the activation of the
secretory and systemic immune responses by lactic acid bacteria requires many
multifaceted interactions among the different components of the intestinal environment.
Enterocytes facilitate a trilogue or communication between luminal bacteria,
epithelial cells and immune cells in the lamina propria. Upon binding and colonization of
the gut, many probiotic strains can influence the host’s mucosal immune system
through the secretion of immune mediators that affect different cell signaling pathways
in mammalian cells (Hemaiswarya et al. 2013). Many immune mediators involved in
innate immune responses are synthesized by intestinal epithelium (Zhang et al. 2010).
Whether the response is pro-inflammatory or anti-inflammatory is dependent on the
individual microorganism in the gut (Neish 2002). Enterocytes can release cytokines
18

such as IL-6, TNF-α and IL-8 when triggered by stimuli (Claud et al. 2003). In vitro,
Caco-2 cells (human colon adenocarcinoma derivative) have been used as a model of
intestinal epithelium because they display structural, morphological and functional
properties that mimic that of intestinal epithelial cells. They spontaneously proliferate
and differentiate, form tight junctions and express high levels of digestive brush border
enzymes (Olejnik et al. 2003). Intestinal epithelial cells can sense microbes or their
components through membrane bound Pattern Recognition Receptors (PRR) like Toll
like receptors (TLR) and nucleotide binding oligomerization domain (NOD) like
receptors. TLR recognize a variety of microbial compounds whereas NOD1 and NOD2
receptors majorly recognize peptidoglycan components (Kingma et al. 2011).

Possible Mechanisms of Gastrointestinal Immunity Stimulation by Probiotics
Major mechanisms of action for Probiotic Lactobacilli include inhibition of
pathogens, maintenance of microbial and immune homeostasis, augmentation of
epithelial barrier function and antimicrobial activity, prevention of inflammation and
modulation of immune responses (Schiffrin and Blum 2002; Fedorak and Madsen 2004;
Marco et al. 2006; Boirivant and Strober 2007; Leeber et al. 2008; Salim and Madsen
2014). Most probiotic Lactobacilli are gram positive, non-sporulating, anaerobic bacteria
(Claeson et al. 2007). Being Gram positive bacteria, Lactobacillus possess conserved
microbe-associated molecular patterns (MAMPs): cell wall exopolysaccharides,
lipoprotein anchors, peptidoglycan, wall teichoic acids (WTA) and lipoteichoic acid (LTA)
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in the cytoplasmic membrane (Lebeer et al. 2008; Baarlen et al. 2013) which are
sensed by Pattern Recognition Receptor (PRRs) (Willing et al. 2010).
Lactobacilli has a thick peptidoglycan complexed with covalent and non-covalent
interactions with teichoic acids, lipoteichoic acids, proteins and polysaccharides
(Delcour, 1999). Teichoic acids which are covalently bonded to peptidoglycan or
attached to cytoplasmic membrane, are “anionic cell wall polymers made up of
polyglycerol phosphate or polyribitol phosphate repeating units” (Neuhas and Baddiley
2003). The cell wall of Lactobacillus rhamnosus and Lactobacillus casei has been
shown to only contain LTA in their peptidoglycan (Perear-Velez et al. 2007). By use of
single-molecule force spectroscopy, study by Francius et al. (2008), reported that
Lactobacillus rhamnosus GG expressed two types of exopolysaccharides: short
glucose-rich and long galactose-rich exopolysaccharides. Lactobacillus rhamnosus GG
was also shown to possess cell surface proteins made up of glycoproteins (Francius et
al. 2008).
The intestinal epithelium has diverse innate immune sensors like the Toll-likereceptors (TLRs) and Nod-Like Receptors (NODs) which are crucial for probiotic-host
interaction (Claes et al. 2012). These receptors could detect ‘Molecular Associated
Molecular Patterns’ (MAMPs) present on commensal bacteria (Ghosh, 2010;
Purchiaroni et al. 2013). These MAMPs interact with TLRs, NODs and C-type lectin
receptors (CLRs) via PRR signaling resulting in the induction of signaling cascades
which drive innate immune responses including production of pro- and anti-inflammatory
cytokines, antigen presentation, activation of immune responses and expression of
antimicrobial factors (Claes et al. 2012; Baarlen et al. 2013). TLRs were the first pattern
20

recognition receptors associated with the recognition of commensal microorganisms
(Rakoff-Nahoum et al. 2004; Slack et al. 2009). In mammals, TLR’s are present on
intestinal epithelial cells, dendritic cells, macrophages and neutrophils, (Purchiaroni et
al. 2013). Muramyl peptides which are present in all Lactobacilli are recognized by
NOD2 receptors (Delcour, 1999). In support, Petnicki-Ocwieja et al. (2009) reported that
the NOD2 expression is dependent on the presence of non-pathogenic bacteria as mice
deficient in NOD2 were found to have higher amounts of commensals. Consequently,
the expression of NOD2 protein can be activated by bacterial peptidoglycan by
triggering mitogen activated protein (MAP) kinase and Nuclear Factor-kappa B (NF-kB)
signalling pathway leading to production of cytokines such as TNFα, IL-1β, IL-8 and
antimicrobial peptides (Cheng and Huang 2013).
Gram-positive bacterial cell-wall components including lipoteichoic acid,
peptidoglycan and muramyl dipeptide were shown to bind to leucocyte Pattern
Recognition Receptors (PRRs), including the endotoxin receptor (CD14), TLR 2 and
Type 1 macrophage scavenger receptor. This could present the possible mechanism
through which probiotics directly stimulate immune responses (Gill and Cross 2002).
Galdeano and Perdigon (2004), in their study demonstrated that probiotics or even their
products could access the intestinal immune system and persist for a certain period of
time and initiate a specific immune response. Interestingly, other beneficial effects of
Lactobacilli on intestinal epithelial cells do not require direct cell contact.
Lactobacillus rhamnosus may secrete proteins into their spent supernatant
thereby triggering specific signaling pathways in intestinal epithelial cells to stimulate or
inhibit cytokine production (Yan and Polk 2002; Yan et al. 2007; Britton and Versalovic
21

2008). Lactobacillus rhamnosus GG have multiple cell surface structures and secreted
factors that have been shown to promote protective role on intestinal epithelial cells via
multiple signaling pathways (Lebeer et al. 2008). Particularly, Lactobacillus rhamnosus
GG was shown to influence inflammatory gene expression via TGF-β and TNF
cytokines. They also influence apoptosis, cell growth and differentiation, cell-cell
signaling, signal transcription/ transduction and cell adhesion indicating its ability to
modulate mucosal immune responses in the intestinal mucosa (Di Caro et al. 2005).
In vitro, some probiotic strains or their products (Fig.1a) may stimulate innate
immune response by inducing TNF-α production by epithelial cells, thereby activating
NF-kB in macrophages and inhibiting host immune response by influencing the
production of IL-8 and subsequent recruitment of neutrophils to the site of infection.
Some strains (Fig.1b) may stimulate the innate immune system by signaling dendritic
cells, which then migrate to mesenteric lymph nodes where they induce T-reg cells
resulting in the release or production of anti-inflammatory cytokines like IL-10 and TGFβ (Gareau et al. 2010 in Harzallah and Belhadj 2013).
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Figure 1 (a) and (b): Potential mechanism of action by probiotics

Probiotic Effects in Inflammatory Cytokine Production in Enterocytes
Cytokines are small molecular weight proteins or peptides, secreted by immune
and non-immune cell and they regulate the duration and intensity of immune responses
(Wenchao et al. 2013). Cytokines are able to alter the character of developing immune
response or inflammatory reaction (Gill and Cross 2002). They act via specific receptors
and, depending on the specific cytokine and the receptors they bind to, they can either
up-regulate or down-regulate the activity of other immune cells. They may exert either
pro-inflammatory or anti-inflammatory effects or both depending on their specific
microenvironments (Su et al. 2011). Cytokine secretion is one of the first immune
responses and can provide information on the nature of infection (Wenchao et al. 2013).
They are extremely potent at low concentrations and their potency is partially due to
23

cascades and networks, whereby the presence of one cytokine leads to the secretion of
others (Stadnyk 1994). Cytokines produced by epithelial cells are grouped as shown in
Table 1.
Table 1. Cytokines Grouped by Function, made by Epithelial Cells

General Function

Cytokine

Inflammatory/ immune regulation IL-1α, IL-1β, IL-6, IL-10, TNFα, LIF, TGF-β
Growth Factors/ differentiation

IL-1α, IL-1β,IL-3,IL -7, TNFα, LIF, TGFβ ,TGFα,
PDGF, G-CSF and GM-CSF

Chemotactic Factors

IL-8, MGSA/gro, MCP-1, CINC

Epithelial Cell Transformation

TGF-α, TGF-β, IL-1, IL-6

Source: (Stadnyk, 1994)
Probiotics have been reported to regulate immune cell signaling pathways,
modulate immunity and induce the production of anti-pathogenic factors by the host
(Britton and Versalovic 2008). The secretion of cytokines from intestinal epithelial cells
when they interact with probiotic bacteria is strain dependent (Kemgang et al. 2014). In
vivo, cytokines released by epithelial cells may function as signals to other immune cells
(Kurchazik et al. 1997). Sartor et al. (2014), stated that several probiotic species or their
products induce the production of cytokines which are protective and critical mediators
of intestinal homeostasis including IL-10 and TGF-β, and may suppress proinflammatory cytokines such as TNF-α (Baarlen et al. 2013). IL-10 is important in
maintenance of immune homeostasis as mice deficient in IL-10 signaling were highly
susceptible to colitis and the severity increased with deficiency in TGF-β signaling
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(Sanjabi et al. 2009). However, it is important to note that inflammatory effects of
probiotics are strain-dependent and their efficacy is dependent on conditions, quality,
dose and concentrations of probiotic preparations (Delcenserie et al. 2008).
Lactobacillus rhamnosus GG, was shown to inhibit pro-inflammatory signaling
and inflammatory cytokine-induced cell death in colonic epithelial cells through a
mechanism that is dependent on epidermal growth factor receptor (EGFR) (Sartor et al.
2014). Previous study by Zhang et al. (2005) noted that in vitro, higher doses of
Lactobacillus rhamnosus GG without TNF-α stimulation induced the production of IL-8.
Both live and heat-killed Lactobacillus rhamnosus GG seemed to down-regulate LPSinduced pro-inflammatory immune mediators and up-regulate anti-inflammatory
mediators in liver, lung and plasma (Nan et al. 2009). In another study, Lactobacillus
rhamnosus GG secreted proteins diminished the production of TNF-α by LPS-activated
macrophages (Pena and Versalovic 2003). Lactobacillus casei DN-114001 was found
to increase mRNA expression of TGF-β and IL-10 in TLR4 knock out mice (Fukata and
Abreu 2007). Studies by Kekkonen et al. (2008a) and Kekkonen et al. (2008b), reported
that Lactobacillus rhamnosus GG appeared to have anti-inflammatory effects as they
were able to reduce inflammatory cytokines and to decrease inflammatory mediators:
sensitive CRP, inflammatory lipid-derived mediators such as lysophosphatidylcholines
and sphingomyelins. Probiotic Lactobacillus plantarum increased the production of antiinflammatory IL-10 and reduced the secretion of pro-inflammatory cytokines; TNF-α, IL1β, IL-6 and IL-8 in TNBS-induced mice (Grangette et al. 2005). In vitro studies with
Caco-2 enterocyte-like cells demonstrated that fermentative Lactobacillus sakei and
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probiotic Lactobacillus johnsonii could stimulate the expression of anti-inflammatory
TGF-β but not pro-inflammatory TNF-α or IL-1β mediators (Gill and Cross, 2002).
Further, the use of leucocytes on Caco-2 cells, Lactobacillus co-culture promoted
the secretion of anti-inflammatory IL-10 and induced the production of pro-inflammatory
mediators by epithelial cells (Gill and Cross 2002, Haller et al. 2000). Research has also
shown that by use of Caco-2 cell culture model in vitro, different probiotics could
stimulate the production of a variety of cytokines prior to interaction with immune system
cells as shown in Figure 2 (Delcenserie et al. 2008).

Adapted from (Delcenserie et al. 2008)
Figure 2. Cytokines produced following interaction between probiotics and intestinal
epithelial cells

In vivo, probiotics can modulate immune cells including dendritic cells and Tregulatory cells. Exposure of dendritic cells to some probiotics may induce antiinflammatory responses and activation of IL-10 producing T-regulatory cells (Salim and
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Madsen, 2014). T-regulatory cells through their IL-10 and TGF-β production are able to
regulate immune responses by inhibiting T-helper 1 and T-helper 2 activities (Gourbeyre
et al. 2010). Certain probiotics could stimulate T-helper1 or T-helper 17 cells to produce
cytokines like IFNγ, IL-12, IL-6 and TNF-α from (Boirivant and Strober 2007) whereas
others may induce T-regulatory cells to produce regulatory cytokines like IL-10 and
TGF-β from (Belkaid and Tarbell 2009; Zhang et al. 2010). The intestinal epithelium is
also capable of releasing some pro-inflammatory chemokines such as IL-8 (Hausmann
et al. 2002). IL-10 can be produced by diverse cells including T Cells, monocytes,
macrophages, dendritic cells and endothelial cells (Dimitrov and Gotova 2014) and they
play a crucial role in inhibiting and diminishing immune and inflammatory responses
(Moore et al. 2001). Dimitrov and Gotova (2014) also found that especially after
stimulation with pro-inflammatory cytokines like TNFα, intestinal epithelium produced
pro-inflammatory chemokine Interleukin 8 (IL-8). They also noted that some LAB strains
with yoghurt origin, could inhibit the secretion of IL-8 from epithelial cells and this could
have a beneficial potential against inflammation.

Transforming Growth Factor-B
Transforming Growth Factor β (TGF-β) is a pleiotropic cytokine with effective
regulatory and/or inflammatory activity and is majorly produced by many immune and
non-immune cells (Li and Flavell 2008; Sanjabi et al. 2009). It is an important antiinflammatory cytokine that is alleged to play a majorly regulate intestinal barrier function
and promote maintenance of peripheral tolerance or tolerance to commensal bacteria
(Dignass and Podolsky 1993; Planchon et al. 1994; Sanjabi et al. 2009). It composes of
27

399 amino acids and it occurs as a homodimer with a total molecular mass of 25kDa;
each monomer molecular mass of 12.5kDa. In vitro, TGF-β is produced by
macrophages and can exert an anti-inflammatory effect during inflammation upon
phagocytosis of apoptotic cells, (Fadok et al. 1998; Su et al. 2011). As an antiinflammatory peptide (Said 1998), TGF-β acts as an immune suppressor. TGF-β has
been shown to induce NF-κB inhibitor thereby inhibiting NF-κB activation (Arsura et al.
1996). It performs cellular functions such as promoting differentiation of IL-10 producing
cells and T-reg cells (Sun et al. 2007; Zheng et al. 2007) and in combination with IL-4,
TGF-β also promotes the differentiation of IL-10 producing cells (Dardalhon et al. 2008).

Interleukin 10
Interleukin 10 is pluripotent, anti-inflammatory cytokine (Asadullah et al. 2003).
Its crystal structure occurs as a homodimer with a total molecular mass of 37kDa. IL-10
monomer is composed of 160 amino acids and has a molecular mass of 18.5kDa
(Mocellin et al. 2004). IL-10 is known to be produced by many immune cells such as
macrophages, monocytes, dendritic cells, T helper-1, T helper-2 and T-reg cells
(Kamanaka et al. 2006). They can also be produced by non-immune cells such as
epithelial cells and keratinocytes (Moore et al. 2001; Williams et al. 2004). As an
immune suppressor, IL-10 is essential for balancing the immune system (Asadullah et
al. 2003; Sanjabi et al. 2009). It transcriptionally controls activation of NF-kB
transcription factor through a negative feedback inhibition and has been shown to
suppress NF-κB nuclear translocation by inhibiting I-kappa B kinase IKK activity and
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delaying the degradation of IκBα or inhibit DNA binding of p65/p50 heterodimers (Moore
et al. 2001). Therefore, IL-10 may exert its anti-inflammatory activity by inhibiting the
NF-κB transcription factor.

Interleukin 8
Interleukin 8 is a pro-inflammatory cytokine. It has a three dimensional structure
with a molecular mass of 11kDa and is composed of 77 amino acids. It is a major
mediator during sepsis (Asha et al. 2007). IL-8 is transcriptionally controlled by NF-κB
transcription factor and it can be rapidly induced by other cytokines such as TNF-α or
IL-1β or bacterial products (Hobbie et al 1997; Mastronade et al. 1998; Hoffman et al.
2002; Hsu-Wei et al. 2010). It primarily functions as a neutrophil chemo-attractant
which stimulates the migration of neutrophils to injured intestinal sites where they
induce inflammatory responses (Claud et al. 2003). According to Delcenserie et al.
(2008), following an interaction between enterocytes and probiotics, IL-8 seems to be
the major cytokine produced. However, probiotic strains differ in their ability to augment
the expression of IL-8. Studies by Zhang et al. (2005) illustrated that the quality and
dose of probiotic preparation may impact the production of IL-8 in enterocytes as higher
doses of live Lactobacillus GG without TNF-α led to increased production of IL-8 in
Caco-2 cell model.

29

Tumor Necrosis Factor α
Tumor Necrosis Factor α (TNFα) is a pro-inflammatory cytokine. Its crystal
structure shows that it occurs as a homo-trimer with a total molecular mass of 51kDa
and is composed of 233 amino acids. Each monomer has a molecular mass of 17kDa.
TNF is widely expressed in granulocytes, fibroblasts, macrophages and epithelial cells
(Spriggs et al. 1992; Parameswaran and Patial 2010). TNF-α is majorly involved in the
activation of transcription factors, multiple signal transduction pathways, and regulation
of many gene transcription via specific cell surface receptors (Shehnaaz et al. 1995).
TNF-α primarily mediates inflammatory responses in various immune system functions
including antimicrobial activity, antitumor activity and mediation of inflammation (Li et al.
2012). As inflammatory mediators, they activate the NF-κB transcription factor by
promoting the phosphorylation and ubiquitination of inhibitor of kappa-B. TNF-α
cytokines are also major mediators during the induction and progression of sepsis
(Asha et al. 2007; Schulte et al. 2013) and they can lead to severe levels of
inflammation in the case of immune dysbiosis (Round and Mazmanian 2009).

NF-κB signalling pathway
NF-κB is a transcription factor that plays an important role in immune regulation
and inflammatory reactions (Lee et al. 2008). Nuclear factor-kappa B (NF-κB) signaling
pathway is the key signaling channel (Fig 3). Intensive communication between the host
intestinal epithelial cells; the initial point of contact and the commensal bacteria or
probiotics greatly influences inflammatory signaling pathways in intestinal epithelial cells
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(Kemgang et al. 2014). NF-κB is a heterodimeric transcription factor comprising of
various subunits namely “p50/p105, p65/RelA, p52/p100, c-Rel and Rel-B” (Scaife et al.
2002). NF-κB is essential for transcriptional activation and regulation of inflammatory
effectors such as IL-8, TNF-α, IL-6, Cox2 and iNOS (LeBlanc et al. 2011). In the
gastrointestinal tract, inflammatory reactions mainly involves the IκB/NF-κB complex
(Lopez et al. 2008).
Under non-stimulatory conditions or in the absence of stimuli, NF-κB exists in its
inactive form in the cytosol where it is bound to its inhibitor molecule, the inhibitor of NFkB (IκB), which inhibits NF-κB translocation into the nucleus thus preventing
transcriptional activities (Beg et al. 1992). Under the influence of stimuli, NF-κB is
activated when IκB is phosphorylated by IκB kinase (IKK) targeting it for ubiquitination
and subsequent proteasomal degradation (Hay et al. 1999). Once dissociated from IκB,
the NF-κB is able to migrate into the nucleus where it binds target promoters and
activates transcription of effector genes like pro-inflammatory genes (Thomas and
Versalovic 2010). Some probiotic strains are able to prevent the proteasomal
degradation of IκB thereby inhibiting the relative expression of pro-inflammatory
cytokines like IL-8 or TNF-α by intestinal epithelial cells.
It has been reported that various LAB strains such as L. acidophilus, L. johnsonii
and L. delbrueckii can suppress inflammatory signals by inhibiting NF-κB activation in a
strain dependent manner (Rocha et al. 2015). NF-κB has been noted to control the
expression of nearly all pro-inflammatory cytokines such as IL-1 α, TNF-α, IL-6 and IL12. They also transcriptionally control the expression of chemokines such as IL-8, cell
surface adhesion molecules and immune receptors including inducible nitric oxide
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synthase, intracellular adhesion molecule 1, T-cell receptor and vascular cell adhesion
molecule 1 (VCAM-1) (Berkes et al. 2003).

Adapted from (Schotellius et al. 1999)
Figure 3. NF-κB signalling pathway

NF-kB function can either be inhibited or altered, directly or indirectly by NF-κB
inhibitors. Direct inhibition of NF-κB involves binding of the inhibitor to the NF-κB
molecule whereas indirect inhibition means the IκB does not bind to NF-κB instead may
reduce the expression, activation or transport of NF-κB to the nucleus by inhibiting IκB
phosphorylation or translation of NF-κB (Kuwaka, 2011). Example of commercially
available indirect NF-κB inhibitor is (2E)-3-[4-(tertiary butyl phenyl) sulfonyl]-2propenenitrile also referred to as BAY-11-7085. IκB BAY 11-7085 has been shown to
inhibit IκB phosphorylation and TNF-α induced NF-κB activation (Pierce et al. 1997).
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Source: Santacruz Biotechnology
Figure 4. Structure of BAY-11-7085

Role of Pro- and Anti-inflammatory Cytokines in Gastrointestinal Disease
Asha et al. (2007), found that pro-inflammatory cytokines play a relevant role in
the initiation and advancement of sepsis. Among those, TNF-α, IL-1β and IL-6 were
important mediators during sepsis. The pro-inflammatory cytokines such as TNF-α and
IL-1β appeared to trigger several events that led to “inflammation, tissue destruction and
loss of function of the normal cellular activities” (Round and Mazmanian 2009). Duary
et al. (2004), stated that by enhancing the immune system of gut, probiotics benefit in
Inflammatory Bowel Disease (IBD) including Crohn's disease and Ulcerative colitis
which are chronic inflammatory diseases of the intestines, characterized by deep
inflammation with granulomas (Purchiaroni et al. 2013).
Crohn’s disease predominantly causes ulcerations which is the breaking of small
and large intestinal lining while ulcerative colitis is a chronic disease of the colon (Duary
et al. 2004). The immune system is tolerant to commensal microorganisms (Duchmann
et al. 1995) and the breakdown of indigenous bacteria and epithelial barrier could lead
to inflammation and result in IBD (Cheng and Huang 2013). There is therefore the need
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to maintain a balance between tolerance towards commensals and reactivity towards
pathogens as deviation from such a balance could lead to upregulation of inflammatory
responses resulting in IBD (Medzhitov 2007). Activation of pro-inflammatory NF-κB
signaling pathway has been thought to be a molecular event involved in IBD
pathogenesis (Jobin and Sartor 2000; Schmid and Alder 2000). Increased expression of
TNF-α resulting in increased NF-κB activation has been reported in IBD - Ulceritis colitis
and Crohn’s Disease (Kaser et al. 2010; Petersen and Round 2014).
Treatment of Crohn's disease includes drugs for suppressing inflammation or the
immune system. The crucial role of IL-10 in the prevention of IBD has been
demonstrated in IL-10 deficient mice where IL-10 downregulates the inflammatory
cascades by suppressing the secretion of pro-inflammatory cytokines (Sanjabi et al.
2009). By strengthening the epithelial barrier and reducing the mucosal levels of proinflammatory cytokines, some probiotics may be effective in the treatment of IBD
(Madsen et al. 2001). Also that probiotic bacterial colonization in the gut may lead to
reduced contact of immune cells to the bacterial antigens which are believed to drive
IBD (Purchiaroni et al. 2013). Also that by altering the microbial environment, some
probiotic components could downregulate inflammation when supplemented to patients
with gastrointestinal diseases (Isolauri et al. 2002). However, it is important to note that
not all probiotics act in the same manner with regards to their anti-inflammatory effects
for example the stimulation of IL-10 producing cells is a strain dependent trait and their
effectiveness depends on the method of administration and the concentrations used
(LeBlanc 2011).
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Why Lactobacillus rhamnosus isolate?
Lactobacillus rhamnosus MRS6AN is a facultative anaerobic lactic acid gram
positive bacteria. It was isolated from a local Kenyan cultured milk “amabere
amaruranu” in Dr. Onyango’s lab, Department of Health Sciences, ETSU, using
16sRNA and biochemical tests among other probiotic potential strains: L. paracasei, L.
casei, L. acidophilus, L. reuteri, and Acetobacter (Boyiri and Onyango 2015).
In Kenya, pastoral communities mainly produce traditional cultured milk products
and some of these fermented milk have been reported to confer health beneficial effects
(Muigei et al. 2013) examples include “kule nato” produced by the Maasai community
(Mathara et al. 2008), “mursik” by the Kalenjin community (Mathara et al. 1995) and
“amabere amarunanu” by the Gusii community (Mokua 2004; Boyiri and Onyango
2015). However, there is no substantial information available concerning the effect of L.
rhamnosus isolated from “amabere amarunanu” on the production of inflammatory
cytokines in the gastrointestinal tract. In addition, the use of Lactobacillus as a probiotic
for humans requires a fine-tuned selection of appropriate strains and a broad
understanding of its action on immune system components (Kemgang et al. 2014).
Therefore, this study used Lactobacillus rhamnosus because previous research
work in the lab found Lactobacillus rhamnosus to have a higher probiotic potential than
the other isolates from “amabere amarunanu”. Lactobacillus rhamnosus did not degrade
mucin, showed stability in acid/bile conditions, had the highest antimicrobial activity
against bacterial test strains and was sensitive to antibiotics (Boyiri and Onyango 2015).
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Hypothesis
Lactobacillus rhamnosus isolated “amabere amarunanu”, a Kenyan traditional
cultured milk preparation will have effects on the production of pro-inflammatory and
anti-inflammatory cytokines in enterocytes.

Objectives
To determine the production of pro- and anti-inflammatory cytokine by Caco-2 cells
when co-cultured with Lactobacillus rhamnosus live culture.
To determine the production of pro- and anti-inflammatory cytokine by Caco-2 cells
when treated with Lactobacillus rhamnosus cell extracts and its filtered spent broth.
To evaluate whether the production of these cytokines in enterocytes is dependent on
NF-κB signaling pathway.
To determine the consequential effect of NF-κB inhibitor in the production of pro- and
anti-inflammatory cytokines in enterocytes.
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CHAPTER 2
MATERIALS AND METHODS
Experimental Materials
Probiotic Lactobacilli Live Cells
The potential probiotic microorganisms (LAB) isolated from a Kenyan traditional
cultured milk “amabere amaruranu” in Dr. Onyango’s lab included L. rhamnosus, L.
paracasei, L. casei, L. acidophilus, L. reuteri, and Acetobacter. This study focused on
Lactobacillus rhamnosus which had been isolated using 16sRNA and identified using
biochemical tests. They were found to have a higher probiotic potential compared to the
other isolates as they did not degrade mucin, showed stability in acid or bile conditions,
had the highest antimicrobial activity against bacterial test strains and was sensitive to
antibiotics (Boyiri and Onyango 2015).

Culture Media for Lactobacillus rhamnosus
The media used in for the growth of Lactobacillus rhamnosus was Thermo
scientific Oxoid deMann Rogosa, Sharpe (MRS) broth (Cat No. CMO359).

Human Enterocyte like Caco-2 Cells
Caco-2 cells are cells that are derived from human colonic adenocarcinoma cells.
After confluence they differentiate into small intestinal-like enterocytes. Their culture
requires 21 day period to attain a differentiated monolayer (Olejnik 2003). Caco-2 cells
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were cultured in Dulbeco’s Modified Eagle’s Media (DMEM) containing 10% fetal bovine
serum (Hyclone, Cat No. SH30088.03, GE Lifecare Healthsciences, Logan, Utah,
84321) and 5% penicillin-streptomycin (Corning Cellgro, Mediatech, Inc, Mannasas, VA
20109) at 37°c, 5% CO2 until they reached 70% confluence. Cells were passaged 2
times and stored in liquid nitrogen in aliquots containing complete DMEM with Dimethyl
Sulfoxide (DMSO) (Corning cellgro, Mediatech, Inc, Mannasas, VA 20109).

Human Enterocyte like Caco-2 Cells Culture Media
The media that was used for culturing Caco-2 cells was Dulbeco’s Modified
Eagle’s Media (DMEM) containing 10% fetal bovine serum (Hyclone, Cat No.
SH30088.03, GE Lifecare Healthsciences, Logan, Utah, 84321) and 5% penicillinstreptomycin (Corning cellgro, Mediatech, Inc, Mannasas, VA 20109).

Lactobacillus rhamnosus Cell Extract
Lactobacillus rhamnosus seed culture was grown by inoculating one storage
bead at -80oc into 5ml MRS broth (Thermoscientific) in a test tube. It was then
incubated at 37 oc under aerobic condition for 12 hours. Ten drops of seed culture were
inoculated into 100ml of MRS broth in a 250ml flask and incubated at 37oc on shaker for
24hrs under aerobic conditions. The OD550nm of the culture was monitored until it
reached OD550nm reading of 2.08nm. Culture (50ml) was dispensed into 50ml centrifuge
tubes and spun at 1100g for 15mins. Supernatant was decanted into clean 50ml screw

38

cork flasks and filtered using a 500ml pre-sterilized steritop and stericup vacuum
filtration and storage system 0.22nm millipore millex filter (Fisher Scientific Co., Cat No.
SCGPU05RE) to produce FSB (filtered spent broth). The cell pellets were washed and
re-suspended in 30ml PBS pH 7.4 (Gibco, Invitrogen). The cell suspension was
sonicated at amplitude 44% for 2 mins with 6min rest, repeated sonication 5 times.
Sonicated suspension was spun at 1100g for 15mins and supernatant was decanted
into clean flask. Supernatant was filtered using 0.22nm millipore millex filter to produce
cytoplasmic fraction (CF). Samples were then stored in -20oc freezer until they were
ready to be used as treatments on Caco-2 cells (Boyiri and Onyango 2015).

Transwells Permeable Support
Caco-2 cell culture was seeded in Transwell permeable supports, 12mm
diameter, 12-well inserts 0.4 µm nucleopore size polycarbonate membrane (Costar,
Corning, Cat No. 29442-086, ME 04043). Transwell inserts have three openings for
standard pipette tips to allow samples to be added or removed from the lower
compartment. Dulbeco’s Modified Eagle’s Media (DMEM) containing 10% fetal bovine
serum (Hyclone, Cat No. SH30088.03, GE Lifecare Healthsciences, Logan, UT 84321)
and 5% penicillin-streptomycin (Corning cellgro, Mediatech, Inc, Mannasas, VA 20109)
was added into the 12 multiple well plate (Costar, Corning, ME 04043). The transwell
insert was then placed into the well. Then, the media was added into the inside
compartment of the transwell insert. To improve cell attachment DMEM media was first
added to the multiple well plate and then to the transwell insert. The plate was then
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incubated for one hour at 37°c, 5% CO2. Caco-2 cells at a density of 2.5×105 cells/ml on
12 mm in cell culture were added on inserts (0.4 µm nucleopore size; Corning, USA)
and cultured 18–22 days at 37°c, 5% CO2 in DMEM containing 10% fetal bovine serum
and 5% penicillin-streptomycin. The media levels were checked periodically and
changed every second day until the cells were fully differentiated at day 21.

Enzyme Linked Immuno-Sorbent Assay (ELISA) Kits
ELISA kits with pre-coated plates (Biolegend) were used to quantify cytokine
produced in the cell culture lysates and the cytokines secreted into the cell culture
supernatants. The kits were stored at 4oc. Human IL-10 (Cat No. 430607) was
composed of anti-human IL-10 pre-coated 96 well strip microplate, human IL-10
detection antibody, standard, avidin-HRP A, assay buffer A, wash buffer (20X),
substrate solution F, stop solution and plate sealers. The human latent TGF-β (Cat No.
432907) was composed of anti-human latent TGF-β pre-coated 96 well strip microplate,
human latent TGF-β detection antibody, standard, avidin-HRP D, assay buffer E, wash
buffer (20X), substrate solution D, stop solution and plate sealers. Human IL-8 (CXCL8)
(Cat No. 431507) was composed of anti-human IL-8 pre-coated 96 well strip microplate,
human IL-8 detection antibody, standard, avidin-HRP A, assay buffer A, wash buffer
(20X), substrate solution F, stop solution and plate sealers. Human TNF-α (Cat No.
430207) anti-human was composed of TNF-α pre-coated 96 well strip microplate,
human TNF-α detection antibody, standard, avidin-HRP B, assay buffer A, wash buffer
(20X), substrate solution D, stop solution and plate sealers.
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Nuclear Factor-kappa B Antibody
The NF-κB antibody that was used in western blotting assay to detect the
presence of NF-κB transcription factor in treated/ untreated Caco-2 cells was rabbit antihuman NF-κB p65 (C-20) Santacruz, Cat No. sc-372). The molecular weight of NF-κB
p65 is 65kDa.

NF-κB Inhibitor
The NF-κB inhibitor that was used in this study was (E)-3-(4-t-Butylphenysufonyl)
-2- propenenitrile (BAY 11-7085 (CAS 196309-76-9), Santacruz Biotechnology, Cat No.
sc-202490). It has a molecular weight of 243.33. It inhibits the activation of NF-κB and
the phosphorylation of IκB. It was solubilized in DMSO (25mg/ml) and stored at -20oc.

Experimental Methods
Growth of Lactobacillus rhamnosus MRS6AN
Probiotic Lactobacillus are nutritionally fastidious and they grow in rich media
containing carbohydrates, amino acids, peptides, fatty acid esters, salts, nucleic acid
derivatives and vitamins (Kandler and Weiss 1986). Lactobacillus rhamnosus were
grown at 37oc overnight in de Mann Rogosa, Sharpe broth in anaerobic conditions to
reach early stationery phase. Lactobacillus rhamnosus was also grown on MRS agar
plate to confirm that it was a pure culture. Bacteria was harvested by centrifugation at
3000g for 5mins at 6oc. They were then washed twice with sterile PBS (pH 7.2). Cells
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were then re-suspended in DMEM media to reach a final concentration of 109 cfu/ml of
media. Live Lactobacillus rhamnosus cells were ready to be transferred to Caco-2 cell
culture.

Caco-2 Cell Culture in DMEM Media
Caco-2 cells were seeded in a biological safety II cabinet in sterile T75 flask and
incubated at 37°C, 5% CO2. The cell culture media was changed every second day until
the cells reached 70% confluence.

Splitting Caco-2 Cells
The 70% confluent Caco-2 cells were then trypsinized with 3ml of Trypsin-EDTA
(Gibco, Grand Island, NY) in 37°C for about 7mins until they were fully detached from
the bottom of the flask. Fresh complete DMEM (5ml) was added to deactivate the
trypsin-EDTA. The cells were then spun at 200g, 5mins in 50ml centrifuge tubes. The
trypsin and media were aspirated from the centrifuged tubes and the cells were resuspended in complete DMEM and were further split and cultured into 6 well plate and
12 transwells. The media was changed every second day until the cells were fully
differentiated at 21day post-confluence.
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Use of Transwells Permeable Support in Caco-2 Cell Culture
Caco-2 cells were seeded at density of 1x100 per well containing 2ml complete
DMEM. Caco-2 cell culture requires 21 day period to attain a differentiated monolayer
(Olejnik 2003). Therefore, the cells were washed and media changed in both the apical
and basolateral side until they were fully differentiated - day 21 (Hallera et.al 2000).

Figure 5. Transwell support

Storage of Caco-2 cells in Liquid Nitrogen
The Caco-2 cells grown in T75 flasks were trypsinized using 3ml trypsin in 37oc
for 7mins. Then DMEM was added to the trypsinized cells and spun at 200g for 5 mins
in 50ml centrifuge tubes. The trypsin and media were aspirated. The cell pellets were
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then rinsed twice with PBS pH7.4 and re-suspended in 5ml DMEM storage media
containing 40% fetal bovine serum and 10% Dimethyl sulfonate (DMSO). Cells were
counted using a hematocytometer and aliquoted into 1ml tubes for storage in liquid
nitrogen.

Co-culture of Caco-2 Cells with Lactobacillus rhamnosus
Lactobacillus rhamnosus were grown at 37ºC in MRS broth in anaerobic
conditions to reach the early stationary phase. They were harvested by centrifugation at
3000g for 5mins at 6ºC. After two washes with sterile PBS pH 7.2 were resuspended in
DMEM to reach a final concentration of 1× 109 cfu/ml of medium. Then the bacteria
were added to the cell culture wells at appropriate dilutions. Caco-2 cells were grown in
DMEM containing 10% fetal calf serum. When grown to confluence in single layer, cells
were washed three times in PBS pH 7.2 to remove culture medium and non-adherent
cells (Boyiri and Onyango 2015). The bacteria in culture medium were transferred into
these wells.
Caco-2 monolayers were apically challenged by addition of 1×109 cfu/ml of
Lactobacillus rhamnosus MRS6AN alone or by stimulation with TNF-α (10 ng/ml,
invitrogen). PBS was used as a negative control. After stimulation for 18hrs (37°c, 5%
CO2), cell culture supernatants were separately collected from the apical and
basolateral compartments, spun at 13,300g, 10mins and stored at −20°C until further
analysis. Adherent Caco-2 cells were washed once with ice-cold PBS (1× pH 7.2) and
lysed in denaturation solution (RIPA buffer + protease inhibitor). They were scrapped off
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from the wells using cell scrapper and transferred to microfuge tubes. The microfuge
tubes were then incubated in ice with agitation for 30mins at 4oc. The lysed cells were
then spun at 13300g, 20mins, 4°c and the supernatants were collected in new
microfuge tubes. The cellular lysates were then stored at −20°c for further analysis

Preparation of Lactobacillus rhamnosus Bacterial Extracts
Lactobacillus rhamnosus seed was cultured by inoculating one storage bead at 80oc into 5ml MRS broth (Thermoscientific) in a test tube. They were then incubated at
37 oc under aerobic conditions for 12 hours. Ten drops of seed culture were inoculated
into 100ml of MRS broth in a 250ml flask and incubated at 37 oc on a shaker for 24hrs
under aerobic conditions. The growth was monitored at optical density (OD550nm) until
they reached OD550nm reading of 2.08nm. Culture (50ml) was dispensed into 50ml
centrifuge tubes and spun at 1100g for 15mins. The supernatant was decanted into
clean 50ml screw cork flasks and filtered using a 500ml pre-sterilized steritop and
stericup vacuum filtration and storage system 0.22nm millipore millex filter (Fisher
Scientific Co., Cat No. SCGPU05RE) to produce FSB (filtered spent broth). Cell pellets
were washed and re-suspended in 30ml PBS pH 7.4 (Gibco, invitrogen). The cell
suspension was then sonicated at amplitude 44% for 2 minutes with 6 minutes rest, the
sonication repeated x5 times. Sonicated suspension was spun at 1100g for 15mins and
supernatant was decanted into clean flask. The supernatant was then filtered with
0.22nm millipore millex filter to produce cytoplasmic fraction (CF). Samples were stored
in -20 oc freezer until they were ready to be used as treatments on Caco-2 cells.
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Treatment of Caco-2 Cells with Lactobacillus rhamnosus Bacterial Extracts
Caco-2 monolayers were apically challenged by addition of 100ul of Lactobacillus
rhamnosus MRS6AN cell extracts: cytoplasmic fraction or 100ul of filtered spent broth.
PBS was used as a negative control. After stimulation for 6-36 hrs (37°c, 5% CO2), cell
culture supernatants were separately collected from the apical and basolateral
compartments, spun at 13300g, 10mins and stored at −20°C until further analysis.
Adherent Caco-2 cells were washed once with ice-cold PBS (1× pH 7.2) and lysed in
denaturation solution (RIPA buffer + protease inhibitor). They were scrapped off from
the wells using cell scrapper and transferred to microfuge tubes. The microfuge tubes
were then incubated in ice with agitation for 30mins at 4oc. The lysed cells were then
spun at 13300g, 20mins, 4°c and the supernatants were collected in new microfuge
tubes. The cellular lysates were then stored at −20°c for further analysis.

ELISA: Enzyme Linked Immuno-sorbent Assay
Sandwich Enzyme Linked Immunosorbent Assays were used to measure the
production of cytokine in the cell lysate and cytokine secretion in the apical and
basolateral supernatants. All the reagents were brought to room temperature prior to
use. All the standards and samples were ran in duplicate. According to the protocol
described in the ELISA Kits: Human IL-10 (Biolegend, Cat No. 430607), Human TNF-α
(Biolegend, Cat No. 430207), Human Latent TGF-β (Biolegend, Cat No. 432907) and
Human IL-8 (Biolegend, 431507). Each of the lyophilized human cytokine (TGF-β, IL-10,
IL-8 and TNF-α) standards were reconstituted by adding assay buffer to make the
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required concentration standard stock solution. The reconstituted standard was allowed
to sit at room temperature for 15-20mins and then vortexed to mix completely. The top
standard was prepared by diluting stock standard stock solution assay buffer in a
polypropylene microfuge tube. Then six two- fold serial dilutions were performed
according to the kits instructions for each cytokine by mixing and transferring 250ul to
the next microfuge tube.
The final human latent TGF-β standard concentrations in the tubes were
100ng/ml, 50ng/ml, 25ng/ml, 12.5ng/ml, 6.25ng/ml, 3.13ng/ml and 1.56ng/ml
respectively. For IL-10 were 250pg/ml, 125pg/ml, 62.5pg/ml, 31.3pg/ml, 15.6pg/ml,
7.8pg/ml and 3.9pg/ml respectively. For IL-8 and TNF-α were 1000pg/ml, 500pg/ml,
250pg/ml, 125pg/ml, 62.5pg/ml, 31.3pg/ml and 15.6pg/ml respectively. Assay buffer
served as the zero standard concentration. Wash buffer (20X) was diluted to 1X with
deionized water. The plates were washed four times with 300ul of 1X wash buffer per
well and any residual buffer was blotted by firmly tapping the plate upside down on
absorbent paper. Assay buffer (50ul) was added to each well containing either the
standards or the samples. Standards (50ul) and samples (50ul) were added to their
appropriate wells, the plates were sealed and incubated for 2 hours at room
temperature while shaking at 200rpm. The contents of the plates were discarded into
the sink then the plate was washed 4 times with 1X wash buffer. The specified volume
of detection antibody solution was added to each well, the plate was sealed and
incubated at room temperature for 1 hour while shaking. The contents of the plates
were discarded into the sink and the plate was washed 4 times with 1X wash buffer.
The specified volume of Avidin-HRP solution was then added into each well, the plates
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were sealed and incubated at room temperature for 30minutes while shaking. The
contents of the plate were then discarded into the sink and the plate was washed 5
times with 1X wash buffer. For the fifth wash the wells were soaked in 1X wash buffer
for 30 seconds to 1 minute to help minimize the background. The prescribed volume
substrate solution was added to each well and incubated at room temperature for the
time specified for each cytokine in the dark. Wells containing cytokines turned blue in
color and their intensity was proportional to their concentration. The reaction was then
stopped by adding 100ul of stop solution to each well. The absorbance was read at
450nm. A standard curve was generated and the concentration of TGF-β, IL-10, IL-8
and TNF-α per sample were determined.

Western Blot Assay for NF-kB Transcription Factor
Loading buffer was prepared by the addition of 50µl of beta mercaptoethanol to
950µl Laemli buffer. Cell lysate samples were prepared by centrifugation at 3000g, 4oC
for 5mins. The samples were loaded into 4-20% Mini-protean TGCTTM gel (Biorad, Cat
No. 456-1096) and were separated by SDS-polyacrylamide gel electrophoresis in 1x
Tris-Glycine SDS page running buffer (30.0g tris base, 144g glycine, 10g sodium
dodecyl sulfate in 1 litre of dH2O). After 1 hr of electrophoresis the gel was transferred
to immunobiolin transfer membrane, pore size 0.45um (Millipore Corporation, Billerica,
MA 01821, Cat No. IPVH00010) in 1x transfer buffer (30.0g tris base, 144g glycine,
200ml methanol in 700ml of dH2O) for 1 hour 30 minutes. The membranes were
blocked in TBS-T (88g NaCl, 2g KCl, 30g Tris base, 5ml tween-20 in I litre of dH2O, pH
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adjusted to 7.4 using HCl) containing 5% non-fat milk. The blots were incubated
overnight at 4oc on a shaker with primary antibody against NF-κB transcription factor
p65 (rabbit anti-NF-kB p65 (C-20), Cat No. sc-372 Santacruz Biotechnology;
www.scbt.com). The membranes was washed three times in 1x TBS-T (10mM Tris –Cl,
pH 7.4, 150mM NaCl, 0.05% Tween-20) for 5 minutes each.
The membranes were then immunoblotted with corresponding secondary
antibodies (Peroxidase-conjugated affinipure donkey anti-rabbit IgG (H+L), Jackson
Immuno Research; www.jacksonimmno.com) on a shaker for 1 hour at room
temperature. The membranes were subsequently washed three times in 1x TBS-T for 5
minutes per wash. Supersignal West Femto reagents (Thermofischer scientific, Cat No.
34095) was prepared by mixing in a ration 1:1 of the reagents in the kit. The mixture
was then added to the membrane and allowed to sit for 5-10 minutes in the dark and
chemiluminescence was developed by exposing the membrane to ultraviolet using
Proteinsimple Flour Chem M. The images were quantified and analysed using Alphaview software and the data was presented as density of the bands relative to the control
bands.

Cell Adhesion Assay
Cells were dispersed and plated at 40,000cells per well in 96-well dishes. The
cells were then treated with live Lactobacillus rhamnosus, its cytoplasmic fraction,
filtered spent broth, heat inactivated broth with or without NF-κB inhibitor BAY 11-7085
for 8-36 hours. Untreated cells and cells only treated with IκB were used as negative
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and positive control respectively. The cells were washed with 100ul/well of ice-cold
PBS. The cells were fixed for 10 mins in 100% ice-cold methanol (100ul/well) then
allowed to air-dry. The cells were stained with 100ul/well of 0.1% crystal violet in H2O for
10 mins, then washed gently four times with ddH2O and four times with PBS. The plates
were then air-dried completely. The stained cells were solubilized in 1% sodium
deoxycholate and the plates read at 590nm in a spectrophotometer. The absorption at
590nm is proportional to the number of cells attached (Scaife et al. 2002).

Treatment of Caco-2 Monolayers with NF-kB Inhibitor (BAY 11-7085)
Bay 11-7085 (10uM) (E)3-[(4-t-Butylphenyl)sulfonyl]-2-propenenitrile (Santacruz
Biotechnology, Cat No. sc-202490) solubilized in dimethyl sulfoxide (DMSO) was used
as a treatment on Caco-2 cell confluent monolayers for one hour before challenge with
overnight live Lactobacillus rhamnosus or its cytoplasmic fraction or filtered spent broth.
Caco-2 cells, bacterial treatments and NF-κB inhibitor BAY 11-7085 were then coincubated for 8-36hours at 37oc, 5% CO2 incubator. After 30 hours of co-incubation, the
plates containing treated Caco-2 cells were placed on ice and were washed with ice
cold PBS, the cells monolayers were scrapped off, harvested and lysed using RIPA
buffer with Protease inhibitor. The cell lysate was spun at 3,000g for 15mins at 4oc. The
samples were stored at -20oc for further analysis.
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Treatment of Caco-2 Monolayers with Heat Inactivated Broth
Filtered spent media from overnight Lactobacillus rhamnosus milk isolate was
boiled at 90oc for 15mins to denature any secreted proteins that may have been present
in the spent media to produce heat inactivated broth (HIB). The heat inactivated broth
(100ul) per well was then used as a Caco-2 cell treatment with the NF-kB inhibitor BAY
11-7085.

Statistical Analysis
Numerical data was analysed as completely randomized design using General
Linear Models GLM in SAS 9.4 software. Means were separated using Least Square
Means (LSM) and Tukey-Kramer methods. The differences in values were considered
statistically significant at P <0.05.
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CHAPTER 3
RESULTS
Cytokine Profiles using ELISA
Caco-2 cells were treated with live Lactobacillus rhamnosus (MRS6AN) milk
isolate, its cytoplasmic fraction (CF), filtered spent broth (FSB). Cell supernatants and
lysates were analyzed using ELISA. The levels of TGF-β were determined in (ng/ml)
and for IL-10, IL-8 and TNF-α in (pg/ml). Caco-2 cell lysate levels of TGF-β and IL-8
were significantly increased in most of the probiotic cell treatments. The various
probiotic treatments did not stimulate production of significant levels of IL-10 and TNF-α
in Caco-2 lysate. Caco-2 cell lysate levels of IL-10 when Caco-2 cells were treated with
(PBS Control, CF, FSB or MRS6AN) were 7.1, 33.6, 31 and 44 pg/ml, respectively; and
of TNF-α were 4.1, 33.1, 30.1 and 27.6pg/ml, respectively.
Generally, there were low levels of TGF-β, IL-8, TNF-α and IL-10 cytokines
secreted into the cell supernatants. Levels of cytokine secretion in the apical
supernatant cell treatments (CF or FSB) for TGF-β were 3.6 and 1.8 ng/ml, respectively.
Live Lactobacillus rhamnosus did not stimulate the secretion of TGF-β into the
supernatants. Levels of cytokine secretion in the apical supernatant cell treatments (CF,
FSB, MRS6AN or MRS6AN + TNFα stimulation) for IL-8 were 96.4, 45.6, 39.0 and 39.6
pg/ml, respectively.
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Anti-inflammatory TGF-β Cytokine
The levels of TGF-β produced when Caco-2 cells were variously treated with
PBS Control, live Lactobacillus rhamnosus (MRS6AN), its cytoplasmic fraction (CF) and
filtered spent broth (FSB) were 15.7, 162.97, 146.51 and 106.88 ng/ml, respectively
(Figure 6). All probiotic treatments significantly increased the production of TGF-β in
Caco-2 cells: MRS6AN (p<0.0001), CF (p<0.0001) and FSB (p<0.0004) when
compared to the control. However, there was no significant mean difference in the
production of TGF-β between the three bacterial treatments.
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Figure 6. Cell lysate levels of TGF-β (ng/ml) produced by Caco-2 cells when treated
with live Lactobacillus rhamnosus (MRS6AN), its cytoplasmic fraction (CF) or filtered
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spent broth (FSB). Each bar represents mean ± SD of TGF-β levels in cell lysate.
Means without a common letter differ, (P<0.05).

Pro-inflammatory IL-8 Cytokine
Caco-2 cells were treated with PBS Control, live Lactobacillus rhamnosus
(MRS6AN), its cytoplasmic fraction (CF), filtered spent broth (FSB) or live Lactobacillus
rhamnosus with TNF-α (10ng/ml) stimulation to induce the production of IL-8. The levels
of pro-inflammatory IL-8 cytokine when Caco-2 cell were treated with PBS control,
MRS6AN, CF, FSB or MRS6AN with TNF-α were 415.45, 887.09, 1453.33, 1849.36
and 2041.21 pg/ml, respectively (Figure 7).
CF, FSB, MRS6AN+TNF-α significantly increased the production of IL-8 in Caco2 cells: CF (p<0.0002), FSB (p<0.0001) and MRS6AN+TNF-α (p< 0.0001) when
compared to the control. Live Lactobacillus rhamnosus with no TNF-α stimulation did
not induce significant production of IL-8. A significant mean difference was observed
between the live probiotic treatment and the other treatments (CF, FSB,
MRS6AN+TNFα).
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Figure 7. Cell lysate levels of IL-8 (pg/ml) produced by Caco-2 cells when treated with
live Lactobacillus rhamnosus (MRS6AN), its cytoplasmic fraction (CF) or filtered spent
broth (FSB). Each bar represents mean ± SD of IL-8 levels in cell lysate. Means without
a common letter differ, (P<0.05).

Expression of NF-κB Transcription Factor
Protein expression of NF-κB was determined in Caco-2 cells lysates treated with
live Lactobacillus rhamnosus, its cytoplasmic fractions or overnight filtered spent broth.
The expression of transcription factor NF-κB p65 was then determined using western
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blot assays (Figure 8a). This was done to ascertain whether the production of these
cytokines in the various probiotic treatments was dependent on NF-κB signaling
pathway. The expression of NF-κB in all the probiotic treatments was quantified and
presented as fold change of band intensity relative to the control (Figure 8b) and Table
2. NF-κB was significantly expressed in Caco-2 cell lysate treatments with CF, FSB and
MRS6AN+ TNFα. There was significant mean difference in NF-kB expression between
live MRS6AN and CF, FSB and MRS6AN with TNF-α treatments.

Figure 8a. Western blot assay image

Table 2. Effect of cytoplasmic fraction (CF), filtered spent broth (FSB), live Lactobacillus
rhamnosus, live Lactobacillus rhamnosus with TNF-α stimulation on the protein
expression of NF-κB p65 in Caco-2 cells.

Relative expressiona

Treatments
Control

0

MRS6AN

19.0

CF

45.3

FSB

49.6

MRS6AN + TNFα

55.6
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Figure 8b. Relative protein expression of NF-κB p65 transcription factor. Effect of
treatments of Caco-2 cells with cytoplasmic fraction, filtered spent broth and live coculture with Lactobacillus rhamnosus or with TNF-α stimulation on the expression of NFκB p65 transcription factor. The expression is presented as fold change relative to the
control where y-axis was set to 0 to normalize the graph to the control. Values are fold
changes of means ± SD relative to the control, means without a common letter differ,
(P<0.05).
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Effect of NF-κB Inhibitor on Cytokine Production
To examine the possible effects of NF-κB inhibitor (IκB BAY 11-7085) on the
production of pro-inflammatory and anti-inflammatory cytokines, fully confluent and
differentiated Caco-2 cells were treated with IκB BAY 11-7085 (10um) for one hour
before challenge with overnight live Lactobacillus rhamnosus culture, its cytoplasmic
fraction, filtered spent broth or live Lactobacillus rhamnosus with TNF-α stimulation. All
bacterial treatments in the presence of NF-kB inhibitor showed increased production of
TGF-β and IL-8. The production of IL-10 and TNF-α cytokines after addition of NF-κB
inhibitor BAY 11-7085 were below detection level. Generally, the presence of IκB
seemed to decrease the production of IL-8 and TGF-β in all cell lysate treatments in
comparison to cell treatments that had no NF-κB inhibitor BAY 11-7085 but the
reduction was not to the baseline (PBS control).

Effect of NF-κB Inhibitor on the Production of TGF-β in Caco-2 Cells
In the presence of NF-kB inhibitor, there was significant production of TGF-β in
all probiotic cell treatments: CF (p<0.0001), FSB (p<0.0001) and MRS6AN (p<0.0001)
when compared to the control (Figure 9). There was however no significant difference of
TGF-β levels between cytoplasmic fraction and live Lactobacillus rhamnosus
treatments. FSB in the presence of IkB significantly increased the production of TGF-β
in Caco-2 cells (p<0.001) in comparison to the other probiotic treatments.
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Figure 9. Cell lysate levels of TGF-β (ng/ml) when Caco-2 cells were treated live
Lactobacillus rhamnosus, its cytoplasmic fraction or filtered spent broth in the presence
of IkB. Each bar represents mean ± SD of TGF-β levels in cell lysate. Means without a
common letter differ, (P<0.05).
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Figure 10. Comparison of the effect of the absence or presence of NF-κB inhibitor on
the production of TGF-β (ng/ml) by Caco-2 cells when treated with live Lactobacillus
rhamnosus, its cytoplasmic fraction, filtered spent broth. Each bar represents mean ±
SD of TGF-β levels in cell lysate. Means without a common letter differ, (P<0.05).

Effect of NF-κB Inhibitor on the Production of IL-8 in Caco-2 Cells
All the probiotic treatments in the presence of inhibitor of NF-kB significantly
increased the production of IL-8: MRS6AN (p<0.005), CF (p<0.002), FSB (p<0.0001)
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and MRS6AN+TNFα (p< 0.0004) when compared to the control (Figure 11). In the
presence of IkB BAY 11-7085, there was no significant difference in the production of
IL-8 between Caco-2 cells treated with live Lactobacillus rhamnosus, its cytoplasmic
fraction or live Lactobacillus rhamnosus with TNF-α stimulation. However, there was
significant difference between cell lysate FSB treatments (p<0.0001) and the other
probiotic treatments (CF, MRS6AN and MRS6AN+TNFα).
c

b
b
b

a

Figure 11. Cell lysate levels of IL-8 (pg/ml) when Caco-2 cells were treated with live
Lactobacillus rhamnosus, its cytoplasmic fraction, filtered spent broth or live
Lactobacillus rhamnosus with TNF-α stimulation in the presence of IkB. Each bar
represents mean ± SD of IL-8 levels in cell lysate. Means without a common letter differ,
(P<0.05).
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Figure 12. Comparison of the effect of the absence or presence of NF-κB inhibitor on
the production of IL-8 (pg/ml) by Caco-2 cell when treated with live Lactobacillus
rhamnosus, its cytoplasmic fraction, filtered spent broth or live Lactobacillus rhamnosus
with TNF-α stimulation. Each bar represents mean ± SD of IL-8 levels in cell lysate.
Means without a common letter differ, (P<0.05).

Effects of Heat Inactivated Broth on the Production of TGF-β and IL-8 Cytokines
Relative to the control, cell lysate levels of TGF-β and IL-8 were notably less
reduced in Caco-2 cells treated with overnight Lactobacillus rhamnosus filtered spent
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broth in the presence of NF-κB inhibitor. To determine whether the spent media had a
heat labile biomolecule, the filtered spent broth was boiled to denature any secreted
proteins that may have been present in the spent media. The heat inactivated broth
(HIB) was then used as a Caco-2 cell treatment with IκB BAY 11-7085. In the presence
of IkB, there was a significant difference in the production of TGF-β between the
HIB+IκB (p<0.0001) when compared to the IkB control. There was also a significant
difference in the production of IL-8 in HIB+IκB (p<0.005) when compared to the IkB
control.
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Figure 13. Cell lysate level of TGF-β (ng/ml) when Caco-2 cells were treated with heat
inactivated broth in the presence of IkB. Each bar represents mean ± SD of TGF-β
levels in cell lysate. Means without a common letter differ, (P<0.05).
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Figure 14. Cell lysate level of IL-8 (pg/ml) when Caco-2 cells were treated with heat
inactivated broth in the presence of IkB. Each bar represents mean ± SD of IL-8 levels
in cell lysate. Means without a common letter differ, (P<0.05).

Comparison of the Effects of FSB and HIB on TGF-β and IL-8 Cytokine Production
The levels of TGF-β and IL-8 were compared after treatments with filtered spent
broth and heat inactivated broth to determine whether there were heat labile
biomolecules that were responsible for the less reduced production of these cytokines in
Caco-2 cells after addition of IkB BAY 11-7085. There was significant mean difference
in TGF-β production between filtered spent broth and heat inactivated broth treatments
(p<0.0076) in the presence of IkB. There was also significant mean difference in IL-8
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production between filtered spent broth and heat inactivated broth treatments
(p<0.0001) in the presence of IkB.
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Figure 15. Comparison between the effects of HIB and FSB on the production of TGF-β
(ng/ml) in Caco-2 cell lysate in the presence of IκB BAY 11-7085. Each bar represents
mean ± SD of IL-8 levels in cell lysate. Means without a common letter differ, (P<0.05).
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Figure 16. Comparison between the effects of HIB and FSB on the production of IL-8 in
Caco-2 cell lysate in the presence of IκB BAY 11-7085. The bars represent the mean
concentration of IL-8 (pg/ml). Values are means ± SD, means without a common letter
differ, (P<0.05).

Effects of NF-κB Inhibitor (IkB BAY 11-7085) on Caco-2 Cell Adhesion
On addition of IκB to the fully confluent and differentiated Caco-2 cells, it was
noted that the cell adhesion of Caco-2 cells was altered. Therefore, a cell adhesion
assay was conducted to determine the varying effects of the presence or absence of
IκB with the bacterial treatments. Caco-2 cells were cultured in a 96 well plate. The cells
were then treated with live Lactobacillus rhamnosus, its cytoplasmic fraction, filtered
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spent broth, heat inactivated broth with or without NF-kB inhibitor for 8-36 hours. The
absorbance was taken at 590nm and each absorbance reading represented cell
attachment. In the presence of IkB and probiotic treatments, it was observed that Caco2 cell adhesion greatly decreased with a significant decrease in the FSB+IkB treatments
(p<0.03) Probiotic treatments alone did not affect Caco-2 cell adhesion in comparison to
the negative control (media alone) untreated cells or positive control (cells treated with
IkB alone).
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Figure 17. Effect of NF-kB inhibitor on adhesion of Caco-2 cells when treated with live
Lactobacillus rhamnosus, its cytoplasmic fraction, filtered spent broth, heat inactivated
broth with or without NF-κB inhibitor for 8-36 hours. Caco-2 cells with DMEM media was
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used as a negative control while cells treated with IκB was used as positive control. A
cell adhesion assay was carried out and the absorbance was taken at 590nm in each
well. The absorbance reading is an equivalent of cell adhesion. The points on the line
represent the mean absorbance for the various treatments. Values are means ± SD,
means without a common letter differ, (p<0.05).
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CHAPTER 4
DISCUSSION AND CONCLUSION
Discussion
Different studies have reported Lactobacillus rhamnsosus to have the potential of
modulating immune responses through epithelial cells (Wallace et al. 2003; Zhang et al.
2005; Lopez et al. 2008). This study therefore examined the effects of Lactobacillus
rhamnosus (MRS6AN) which was isolated using 16sRNA and biochemical tests from
“amabere amarunanu” a Kenyan traditional cultured milk (Boyiri and Onyango 2015) on
the production of pro-inflammatory and anti-inflammatory cytokines in enterocytes. This
study hypothesized that probiotic treatments such as live Lactobacillus rhamnosus, its
cell extracts, or filtered spent broth on enterocytes would have an effect on the
production of pro-inflammatory cytokines; Interleukin 8 (IL-8) and Tumor Necrosis
Factor–α (TNFα) and anti-inflammatory cytokines; Interleukin 10 (IL-10) and
Transforming Growth Factor–β (TGF-β) in Caco-2 cells.
Probiotic cells extracts were used in this study because even though probiotics
should be administered as live micro-organisms, yet isolated components from the
probiotic cells have been shown to have therapeutic effects (Rachmilewitz et al. 2002).
At single-celled level, epithelial cells mostly show characteristics of polarization, having
unique apical and basal surface features with vectorial functions (Schoenenberger and
Matlin 1991). Therefore, Caco-2 cell model was used in this study because they mimic
important properties structural, morphological and functional properties of the mucosal
epithelium. After confluence, they stop to proliferate and start to undergo a spontaneous
polarized differentiation (Chantret et al. 1988).
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Enzyme Linked Immunosorbent Assays (ELISA) showed very low levels of
cytokine secretion in both basolateral and apical supernatants. Parlesak et al. (2004)
and Haller et al. (2000) argued that basic stimulation of enterocytes with commensal
bacteria without inducing cytokine secretion via LPS or cytokines or co-culture with
leucocytes may result in low secretion of cytokine in cell supernatant. In this study, it
was observed that secretion of both anti-inflammatory (TGF-β) and pro-inflammatory
(IL-8) mostly occurred in apical cell supernatant with the various treatments. This could
be due to the ability of intestinal epithelial cells to establish their response and to
produce immune mediators in a bidirectional and vectorial manner (Sonnier, et al.
2010).
This study found that Caco-2 cells were directly responsive to challenge by live
Lactobacillus rhamnosus, its cell extracts or overnight spent media as they had
differential stimulation in the production of inflammatory cytokines in enterocytes. All
probiotic treatments (MRS6AN, CF or FSB) showed significant increased levels of TGFβ in differentiated Caco-2 cells compared to the PBS control. Lactobacillus rhamnosus
cell extract, its ovenight spent media or live Lactobacillus rhamnosus with TNF-α
stimulation induced a significant increased production of IL-8 cytokines in differentiated
Caco-2 cells compared with the PBS control and live Lactobacillus rhamnosus
treatments. Live Lactobacillus rhamnosus alone did not stimulate significant production
of IL-8 in Caco-2 cells. This coincides with Zhang et al. (2005) who found that both living
and dead Lactobacillus rhamnosus GG inhibit IL-8 production by Caco-2 cells via
interference with the NF-kB activation. This also supports previous study by Lopez et al.
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(2008) who reported a decreased production of IL-8 in intestinal epithelium by live
Lactobacillus rhamnosus GG.
It was observed that live Lactobacillus rhamnosus, its cytoplasmic fraction or
filtered spent broth stimulated a significant increased production of TGF-β which was
measured in nanograms/ml compared to the production of IL-8 which was measured in
picograms/ml in the various probiotic treatments. This showed that Lactobacillus
rhamnosus, its cell extracts or secreted products majorly stimulates the production of
anti-inflammatory TGF-β cytokines. Taken together, these results indicate that the
whole probiotic bacterial cell or its cell extracts or secreted products have differential
immunomodulation properties and effects in the production of inflammatory cytokines in
enterocytes.
Possible mechanisms through which probiotics influence differential immunomodulatory activities have been discussed in different studies. Lactobacillus rhamnosus
has been found to have different conserved microbe-associated molecular patterns
(MAMPs) including the presence of lipoteichoic acid in their peptidoglycan (PerearVelez et al. 2007), short glucose-rich and long galactose rich exopolysaccharides and
cell surface glycoproteins (Francius, et al. 2008) which could bind to various Pattern
Recognition Receptors on enterocytes such as TLR or NODs and trigger different
immunomodulatory effects in enterocytes. Hardy et al. (2013), noted that probiotic
bacterial products may exert their immuno-modulatory or stimulatory effects by direct
interaction with the host cells or via secreted probiotic products. In this study, cell free
supernatants or filtered spent broth were found to significantly increase the production
of both TGF-β and IL-8 suggesting the capacity of probiotic Lactobacillus rhamnosus to
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have immunomodulatory effects via the production and secretion of metabolites into its
media. This agrees with Yan and Polk, (2002) and Yan et al. (2007) who reported that
Lactobacillus rhamnosus secrete proteins into their spent supernatant and this may
trigger specific signaling pathways in intestinal epithelial cells.
Further, multiple cell surface and secreted factors of Lactobacillus rhamnsosus
GG were shown to exert protective effects on intestinal epithelial cells via multiple
signaling pathway (Lebeer et al. 2008). Two secreted proteins; p40 and p75 (Yan et al.
2007) which are obtained from proteins marked as surface antigen and cell wall
associated glycoside hydrolase have been reported to promote the survival and growth
of intestinal epithelial cells (Claes et al. 2012). Kankainen et al. (2009) noted that the
genome of probiotic Lactobacillus rhamnosus GG contains pilin encoding spaBCA
operon which has been shown to bind to mucus and has been proposed to modulate IL
8 mRNA expression induced by surface molecules like LTA in Caco-2 cells (Lebeer et
al. 2012). Also, in vitro, Illiev et al. (2005) reported that Lactobacillus rhamnosus GG
chromosomal DNA to contain a specific, immunogenic structure that stimulated both
human and murine lymphocytes indicating that not only live Lactobacillus rhamnosus
GG but also its structural components may have immunomodulatory effects. A previous
research exhibited that Lactobacillus rhamnosus GG influenced inflammatory gene
expression via TGF-β cytokines (Di Caro et al. 2005).
In this study, it was observed that treatment with live Lactobacillus rhamnosus
alone did not stimulate the production of IL-8 whereas live Lactobacillus rhamnosus with
TNF-α stimulation showed a significant increased production of IL-8. This agrees with
Stadnyk, (1994) who was studying the cascade effect of cytokines and stated that
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epithelial cells may be induced to make cytokines by treatment with other cytokines. It
has been reported that IL-8 can be synthesized by many different cell types and its
production is mostly induced by a wide range of stimuli or ligands including TNF-α and
bacterial products (Stadnyk 1994; Hoffman et al. 2002). Expression of IL-8 has been
shown to be mostly regulated by stimuli like TNF-α (Xie 2001) but their expression may
however be dose-dependent as Zhang et al. (2005) reported that when higher doses of
Lactobacillus rhamnosus GG were co-incubated with Caco-2 cells, less IL-8 was
produced via TNFα-stimulation.
Following an encounter with probiotic organism, IL-8 seems to be the major proinflammatory cytokine produced by enterocytes (Delcenserie et al. 2008) and its
production has been reported to be transcriptionally controlled by NF-κB transcription
factor (Hoffman et al. 2002; Smith et al. 2001). This study carried out western blot
assays of NF-kB to ascertain whether cytokines production by enterocytes was
dependent on NF-κB signal transduction pathway. Protein NF-κB p65 was expressed as
band intensities in all the treatments with significant increased expression in CF, FSB
and live Lactobacillus rhamnosus co-culture with TNF-α stimulation. These findings
therefore support the study by Miettinen et al. (2000), who found that Lactobacillus
rhamnosus GG activated transcription factor NF-κB, which is the central activator of the
innate immune response and Toll-like receptors TLR1 and TLR2 which mediate
bacterial recognition and cellular signaling. They further reported that Lactobacillus
rhamnosus GG is able to induce a cascade of immunological events in the gut epithelial
cells because it is recognized by the TLR2 receptor (Miettinen et al. 2008). Studies have
also reported that significant IL-8 expression partly requires activation of NF-κB
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transcription factor which in turn is sometimes regulated by protein kinase pathway
(Hoffman et al. 2002). NF-κB signaling pathway is involved in the regulation of a wide
spectrum of biological activities including regulation of inflammatory responses, cell
proliferation, differentiation, apoptosis, lipid metabolism and coagulation (Li et al. 2012).
According to Pierce et al. (1997), NF-kB could be inhibited by two major inhibitors
which are commercially available: BAY 11-7082 and BAY 11-7085 which have been
shown to inhibit IκB phosphorylation and TNF-α induced NF-κB activation. To determine
whether NF-κB signaling pathway had an effect on the production of these inflammatory
cytokines, NF-κB inhibitor (BAY 11-7085) was added to Caco-2 cells one hour before
treatment with the various probiotic treatments and the levels of TGF-β, IL-10, IL-8 and
TNF-α, were measured using ELISA. After inhibition with IκB BAY 11-7085, it was
observed that there was still significant production of TGF-B and IL-8 levels in Caco-2
cell lysate treatments compared to the control but their levels were remarkably
decreased compared to their levels in the absence of NF-kB inhibitor. This suggested
that apart from NF-kB signaling pathway, the production of TGF-B and IL-8 in Caco-2
cell lysate treatments could be transcriptionally regulated via other cell signaling
pathways. Levels of IL-10 and TNF-α after treatment with IκB BAY 11-7085 were below
their detection limits. Interestingly, concentration levels of TGF-β which is majorly
regulated by SMAD pathway (Bitzer et al. 2000) were also affected by the inhibition of
the NF-κB signaling pathway. This may suggest that immunomodulatory signaling
pathways are interdependent or inter-related.
Compared to the other treatments, after inhibition of NF-kB by BAY 11-7085, it
was observed that the concentration of TGF-β and IL-8 were less reduced in the filtered
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spent broth treatments. This suggested that Lactobacillus rhamnosus ovenight spent
media may have some secreted products that stimulate the production of TGF-β and IL8 via a different signaling pathway. To determine whether the spent media had a heat
labile biomolecule, differentiated Caco-2 cell monolayers were treated with heat
inactivated broth (HIB). There was still significant production of TGF-β and IL-8 in Caco2 cell lysate treatments with HIB indicating that the the presence of heat labile
biomolecules with immunostimulatory properties. However, the levels of TGF-β and IL-8
in FSB treatments were significantly increased in comparison to their levels in HIB
treatments. This suggested the presence of other immune stimulatory soluble factors in
the overnight Lactobacillus rhamnosus spent media that are not basically heat labile. It
also suggested that Lactobacillus rhamnosus secreted products in the spent media may
regulate inflammatory responses partly via NF-κB signaling pathways. Study by
Hoffman et al. (2002) who investigated the multiple signaling pathways that regulate the
production or expression of IL-8 found that apart from NF-kB, there are three mitogenactivated protein kinase (MAPK) pathways that contribute to IL-8 gene expression
including the extracellular-regulated protein kinase (ERK), JUN-N-terminal protein
kinase (JNK) and p38 MAPK cascades.
Another important observation was that the presence of IκB (10uM) together with
the various probiotic treatments significantly inhibited the adhesion of Caco-2 cells in
comparison to probiotic cell treatments in the absence of IκB. The absorbance detected
in the cell adhesion assay was an equivalent of adherent Caco-2 cells. This indicated a
possible relationship between Caco-2 cell adhesion and NF-kB signaling pathway in
mucosal enterocytes. Studies by patent Kumaka, (2011) and Scaife et al. (2002)
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demonstrated that high concentrations of BAY 11-7085 was responsible for the rapid
inhibition of cell adhesion in colon cancer cell lines (HT-29 cells) and suggested that
NF-κB promoted cell adhesion. Transcriptional activator NF-kB has been found to
regulate the genes of cell adhesion molecules, acute phase proteins cytokines,
hemapoietic growth factors and transcription factors (Bitzer et al. 2000).

Conclusion

In conclusion, live Lactobacillus rhamnosus, its cell extracts or secreted products
significantly increased the levels of TGF-β and IL-8 in Caco-2 cells. The increase in the
levels of anti-inflammatory TGF-β was on average about 100x more compared to the
increase in the pro-inflammatory IL-8 indicating that Lactobacillus rhamnosus
treatments majorly stimulate anti-inflammatory responses in enterocytes. Inhibition of
NF-κB significantly reduced the levels of TGF-β and IL-8 stimulated by the various
Lactobacillus rhamnosus treatments on Caco-2 cells. However, the levels of TGF-β and
IL-8 were not completely diminished after inhibition. This may be an indication that the
transcriptional regulation of inflammatory cytokine production in enterocytes is partly via
NF-κB signaling pathway.

After NF-κB inhibition, TGF-β and IL-8 levels were less reduced in FSB
treatments (filtered overnight culture media of L. rhamnosus) compared to heat treated
FSB (HIB) treatments. This may be an indication of the presence, in FSB, of other
immune stimulatory soluble factors that are not heat labile. This study has also shown
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that there is a possible relationship between Caco-2 cell adhesion and NF-κB signaling
pathway because NF-κB inhibition led to a significant decreased Caco-2 cell adhesion.

Future Research
Since there was notable but varying inflammatory modulatory effects of whole
live Lactobacillus rhamnosus milk isolate and its cytoplasmic fraction or filtered spent
broth, there is therefore the need to characterize and further investigate the specific
probiotic Commensal Associated Molecular Pattern (CAMPs) such as peptidoglycan,
lipoteichoic acids, genes and their secreted products in the spent media responsible for
such responses.
A further study should be carried out to determine the other signaling pathways
that could transcriptionally regulate the production of inflammatory cytokines especially
in the overnight spent media treatments on Caco-2 cells. The findings of this study were
based on cell line experimental models which may not necessarily represent the actual
in vivo situation, therefore it may be important to carry out this study in an animal model.
Also the co-culture of the milk isolate Lactobacillus rhamnosus and treatments
with their extracts or filtered spent broth on Caco-2 cells could be carried out in a
transwell model with leucocyte basolateral stimulation and or with cytokine/
lipopolysaccharide apical stimulation to further determine the effect of interaction or
communication between the probiotic milk isolate, intestinal epithelial cells and immune
cells on the production of various inflammatory cytokines.
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